Glycolysis as a target for the design of new anti-trypanosome drugs

Drug Resistance Updates

Volumn 4, Issue 1, 2001, Pages 50-65

  Verlinde, Christophe L M J ^a   Hannaert, Véronique ^b   Blonski, Casimir ^c   Willson, Michèle ^c   Périé, Jacques J ^c   Fothergill Gilmore, Linda A ^d   Opperdoes, Fred R ^b   Gelb, Michael H ^a   Hol, Wim G J ^a,e   Michels, Paul A M ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b DE DUVE INSTITUTE   (Belgium)

^c UPS)   (France)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITRYPANOSOMAL AGENT; EFLORNITHINE; ENZYME INHIBITOR; MICROBIAL ENZYME; ZANAMIVIR;

DRUG DESIGN; DRUG TARGETING; ENZYME INHIBITION; ENZYME KINETICS; ENZYME STRUCTURE; GLYCOLYSIS; HUMAN; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TRYPANOSOMA;

EID: 0035062226     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2000.0177     Document Type: Article

References (105)

1. Therapy of human African trypanosomiasis: Current situation
2. Recent advances in identifying and validating drug targets in trypanosomes and leishmanias
3. Compartmentation of carbohydrate metabolism in African trypanosomes
4. Metabolic compartmentation in African trypanosomes
5. Differences in energy metabolism between Typanosomatidae
6. Aerobic fermentation of glucose by Trypanosomatidae
7. Evolution of nuclear ribosomal RNAs in kinetoplastid protozoa: Perspectives on the age and origins of parasitism
8. Localization of nine glycolytic enzymes in a microbodylike organelle in Trypanosoma brucei: The glycosome
9. Regulation of glycolysis in Trypanosoma brucei: Hexokinase and phosphofructokinase activity
10. Purification and regulatory properties of phosphofructokinase from Trypanosoma (Trypanozoon) brucei brucei
11. Compartmentation protects trypanosomes from the dangerous design of glycolysis
12. Metabolic aspects of glycosomes in Trypanosomatidate - New data and views
13. An essential role of triosephosphate isomerase and aerobic metabolism in trypanosomes
14. Specificity of glucose transport in Trypanosoma brucei. Effective inhibition by phloretin and cytochalasin
15. Inhibition of glyceraldehyde-3-phosphate dehydrogenase by pentalenolactone in Trypanosoma brucei
16. Glucose catabolism in African trypanosomes. Evidence that the terminal step is catalyzed by a pyruvate transporter capable of facilitating uptake of toxic analogs
17. The inhibition of pyruvate transport across the plasma membrane of the bloodstream form of Trypanosoma brucei and its metabolic implications
18. New approach to screening drugs for activity against African trypanosomes
19. Trypanosoma brucei; trypanocidal effect of salicylhydroxamic acid plus glycerol in infected rats
20. An antibiotic, ascofuranone, specifically inhibits respiration and in vitro growth of long slender bloodstream forms of Trypanosoma brucei brucei
21. Aerobic glucose fermentation by Trypanosoma cruzi axenic culture amastigote-like forms during growth and differentiation to epimastigotes
22. Leishmania mexicana: Energy metabolism of amastigotes and promastigotes
23. A gene encoding the plant-like alternative oxidase is present in Phytomonas but absent in Leishmania spp.
24. What controls glycolysis in bloodstream form Trypanosoma brucei?
25. Metabolic control analysis of glycolysis in trypanosomes as an approach to improve selectivity and effectiveness of drugs
26. Suicide enzyme inhibitors as potential drugs
27. The behavior and significance of slow-binding enzyme inhibitors
28. Significance of slow-binding enzyme inhibition and its relationship to reaction intermediate analogs
29. Drug design against a shifting target: A structural basis for resistance to inhibitors in a variant influenza virus neuraminidase
30. Regulation and control of compartmentalized glycolysis in bloodstream form Trypanosoma brucei
31. Glycolysis in bloodstream form Trypanosoma brucei can be understood in terms of the kinetics of the glycolytic enzymes
32. Glycolysis in Trypanosoma brucei
33. Glycolytic enzymes of Trypanosoma brucei. Simultaneous purification, intraglycosomal concentrations and physical properties
34. Prospects for antiparasitic drugs. The case of Trypanosoma brucei, the causative agent of African sleeping sickness
35. Using metabolic control analysis to improve the selectivity and effectiveness of drugs against parasitic diseases
36. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase
37. Structure-based drug design: Progress, results and challenges
38. Evolution of glycolysis
39. Structure of type 2 peroxisomal targeting signals in two trypanosomatid aldolases
40. Refined 1.83 Å structure of trypanosomal triosephosphate isomerase crystallized in the presence of 2.4 M-ammonium sulphate. A comparison with the structure of the trypanosomal triosephosphate isomerase - Glycerol-3-phosphate complex
41. Differences in the intersubunit contacts in triosephosphate isomerase from two closely related pathogenic trypanosomes
42. Structural and mutagenesis studies of leishmania triosephosphate isomerase: A point mutation can convert a mesophilic enzyme into a superstable enzyme without losing catalytic power
43. Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data
44. Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase: Structure, catalytic mechanism and targeted inhibitor design
45. Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: Implications for structure-based drug design and a new position for the inorganic phosphate binding site
46. Synergistic effects of substrate-induced conformational changes in phosphoglycerate kinase activation
47. The structure of pyruvate kinase from Leishmania mexicana reveals details of the allosteric transition and unusual effector specificity
48. A potential target enzyme for trypanocidal drugs revealed by the crystal structure of NAD-dependent glycerol-3-phosphate dehydrogenase from Leishmania mexicana
49. Evolution and regulatory role of the hexokinases
50. The mechanism of regulation of hexokinase: New insights from the crystal structure of recombinant human brain hexokinase complexed with glucose and glucose-6-phosphate
51. Binding of non-catalytic ATP to human hexokinase I highlights the structural components for enzyme-membrane association control
52. Yeast hexokinase inhibitors designed from the 3-D enzyme structure rebuilding
53. Fourier transform infrared spectroscopic study of yeast hexokinase: Conformational changes under interaction with substrates and inhibitors
54. Inhibition of yeast hexokinase: A kinetic and phosphorus nuclear magnetic resonance study
55. Glucosephosphate isomerase from Trypanosoma brucei. Cloning and characterization of the gene and analysis of the enzyme
56. Subcellular distribution and characterization of glucosephosphate isomerase in Leishmania mexicana mexicana
57. The crystal structure of a multifunctional protein: Phosphoglucose isomerase/autocrine motility factor/neuroleukin
58. Crystal structure of rabbit phosphoglucose isomerase, a glycolytic enzyme that moonlights as neuroleukin, autocrine motility factor, and differentiation mediator
59. The glycosomal ATP-dependent phosphofructokinase of Trypanosoma brucei must have evolved from an ancestral pyrophosphate-dependent enzyme
60. Structure and control of phosphofructokinase from Bacillus stearothermophilus
61. Crystal structure of the complex of phosphofructokinase from Escherichia coli with its reaction products
62. An easy stereospecific synthesis of 1-amino-2,5-anhydro- 1 -deoxy-D-mannitol and arylamino derivatives
63. Activity and specificity of human aldolases
64. Crystal structure of human muscle aldolase complexed with fructose 1,6-bisphosphate: Mechanistic implications
65. Inhibition of the glycolytic enzymes in the trypanosome: An approach in the development of new leads in the therapy of parasitic diseases
66. Slow reversible inhibitions of rabbit muscle aldolase with substrate analogues: Synthesis, enzymatic kinetics and UV difference spectroscopy studies
67. Class I aldolases: Substrate specificity, mechanism, inhibitors and structural aspects
68. Inhibition of rabbit muscle aldolase by phosphorylated aromatic compounds
69. The crystal structure of the "open" and the "closed" conformation of the flexible loop of trypanosomal triosephosphate isomerase
70. Crystal structure of recombinant human triosephosphate isomerase at 2.8 Å resolution. Triosephosphate isomerase-related human genetic disorders and comparison with the trypanosomal enzyme
71. In search of new lead compounds for trypanosomiasis drug design: A protein structure-based linked-fragment approach
72. Structure of the complex between trypanosoml triosephosphate isomerase and N-hydroxy-4-phosphono-butanamide: Binding at the active site despite an "open" flexible loop conformation
73. Using evolutionary changes to achieve species-specific inhibition of enzyme action-studies with triosephosphate isomerase
74. Derivatization of the interface cysteine of triosephosphate isomerase from Trypanosoma brucei and Trypanosoma cruzi as probe of the interrelationship between the catalytic sites and the dimer interface
75. Twinning in crystals of human skeletal muscle D-glyceraldehyde-3-phosphate dehydrogenase
76. Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: Toward new drugs for the treatment of sleeping sickness
77. Synthesis and conformational analysis of 2′-deoxy-2′-(3-methoxybenzamido) adenosine, a rational-designed inhibitor of trypanosomal glyceraldehyde phosphate dehydrogenase (GAPDH)
78. Synthesis and structure-activity relationships of analogs of 2′-deoxy-2′-(3-methoxybenzamido) adenosine, a selective inhibitor of trypanosomal glycosomal glyceraldehyde-3-phosphate dehydrogenase
79. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design
80. Inhibition of glyceraldehyde-3-phosphate dehydrogenase by phosphorylated epoxides and alpha-enones
81. Selective inhibition of Trypanosoma brucei glyceraldehyde-3-phosphate dehydrogenase by 1,3-bisphospho-D-glyceric acid (1,3-diPG) analogues
82. Crystal structure of the binary complex of pig muscle phosphoglycerate kinase and its substrate 3-phospho-D-glycerate
83. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: Elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine
84. Trypanosoma brucei contains a 2,3-bisphosphoglycerate independent phosphoglycerate mutase
85. Structure and mechanism of action of a novel phosphoglycerate mutase from Bacillus stearothermophilus
86. Enolase from Trypanosoma brucei, from the amitochondriate protis Mastigamoeba balamuthi, and from the and cytosol of Euglena gracilis: Pieces in the evolutionary puzzle of the eukaryotic glycolytic pathway
87. 6 topology
88. X-ray structure and catalytic mechanism of lobster enolase
89. Stimulation of Trypanosoma brucei pyruvate kinase by fructose 2,6-bisphosphate
90. Molecular cloning and analysis of two tandemly linked genes for pyruvate kinase of Trypanosoma brucei
91. Pyruvate kinase of Leishmania mexicana mexicana. Cloning and analysis of the gene, over expression in Escherichia coli and characterization of the enzyme
92. The structure of cat muscle pyruvate kinase
93. +, and pyruvate
94. The allosteric regulation of pyruvate kinase
95. Cloning and characterization of the NAD-linked glycerol-3-phosphate dehydrogenases of Trypanosoma brucei brucei and Leishmania mexicana mexicana and expression of the trypanosome enzyme in Escherichia coli
96. Glycerol kinase of Trypanosoma brucei. Cloning, molecular characterization and mutagenesis
97. Structure of the regulatory complex of Escherichia coli IIIGlc with glycerol kinase
98. Cloning, sequencing, and functional activity of the Trypanosoma brucei brucei alternative oxidase
99. Compartmentation of phosphoglycerate kinase in Trypanosoma brucei plays a critical role in parasite energy metabolism
100. Kinetoplastid glucose transporters
101. +-ATPase regulate the intracellular pH of Trypanosoma brucei at different stages of its life cycle
102. Proteins involved in peroxisome biogenesis and functioning
103. Elongation and clustering of glycosomes in Trypanosoma brucei overexpressing the glycosomal Pexl l p
104. Cloning and analysis of the PTS-I receptor in Trypanosoma brucei